CTKB Working Capital Ratio

Cytek Biosciences Inc · Working Capital Ratio

CTKB logo

CTKB Working Capital Ratio

Latest reported68.07%
CTKB FY Working Capital Ratio (66.41% → 68.07%)
High-resolution chart · PNG

CTKB working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytek Biosciences Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
68.0744%
65.8224%
67.9198%
77.9593%
86.0237%
82.7743%
66.4089%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.